What we found on the web about Ropinirole
Ropinirole - Wikipedia, the free encyclopedia
Ropinirole (marketed under the brand names Requip and Ropark, in extended release form as Requip XL) is a non-ergoline dopamine agonist. It is manufactured by GlaxoSmithKline and ...
Restless legs syndrome - Wikipedia, the free encyclopedia
Dopamine agonists such as ropinirole, pramipexole, carbidopa / levodopa or pergolide. Ropinirole (Requip) was first approved In 2005 by the US Food and Drug Administration (FDA) to treat ...
MedlinePlus Drug Information: Ropinirole
Why is this medication prescribed? Return to top. Ropinirole is used alone or with other medications to treat the symptoms of Parkinson's disease (PD; a disorder of the ...
Ropinirole ( ReQuip )
ropinirole: a new dopamine receptor agonist. ... Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist
Ropinirole - usage and dosage
Using ropinirole and forms of dosage ... Ropinirole comes as a pill that is to be taken orally. Take this medication exactly as it was prescribed for you.
Ropinirole ( ReQuip )
Ropinirole for antidepressant-induced sexual dysfunction by Worthington JJ, Simon NM, Korbly NB, Perlis RH, Pollack MH; For the Anxiety Disorders Research Program.
ropinirole - definition of ropinirole in the Medical dictionary - by ...
ropinirole /ro·pin·i·role/ (ro-pin´ĭ-rōl″) a dopamine agonist used as the hydrochloride salt as an antidyskinetic in the treatment of Parkinson's disease.
Ropinirole
Ropinirole is a dopamine agonist used to treat muscle rigidity and stiffness in diseases like Parkinson's. This eMedTV segment takes an in-depth look at this medication, including ...
Requip for Consumers: Requip / Requip XL
IMPORTANT NOTE: REQUIP XL has not been studied in Restless Legs Syndrome (RLS) and is not approved for the treatment of RLS. However, an immediate-release form of ropinirole ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Ropinirole

Ropinirole (Requip, Ropark, Adartrel) is a non-ergoline dopamine agonist. It is manufactured by GlaxoSmithKline (GSK) and Sun Pharmaceutical. It is used in the treatment of Parkinson's disease. Ropinirole is also one of two medications in the United States (U.S.) with an Food and Drug Administration (FDA) approved indication for the treatment of restless legs syndrome (RLS), the other being pramipexole (Mirapex). The discovery of the drug's utility in RLS has been used as a successful example of drug repurposing. Note: The opinion that ropinirole's use in RLS was a successful example of drug repurposes was reported as being that of Josef Scheiber, a post-doctoral fellow at the Novartis Institutes for BioMedical Research.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Ropinirole
Stimulating the brain
Arizona Daily Star
Sherman addresses the mental confusion. "Having the DBS might make some of the memory problems worse. It could be partially the high dose of ropinirole. That drug stood by you for a very long time. We'll work on reducing that."
GSK and Skyepharma suffer setback
Financial Times
The Food and Drug Administration deferred its decision on the drug, an extended release version of GSK’s Requip also known as Ropinirole, after the company submitted additional information on the food effects of the medicine last month in r...
Parkinson's drugs up compulsive behaviors
Presstv
Taking therapeutic doses of certain Parkinson's medication can place the patients at a higher risk of developing unhealthy behaviors. Dopamine agonists such as pramipexole and ropinirole are a class of drugs commonly prescribed in Parkinson...
Parkinson's Disease Latest Update: Market upgrade following evidence ...
TMCnet
GlaxoSmithKline's Requip XL (ropinirole extended-release) is set to become the market leading dopamine agonist in 2009. The convenience of once-daily dosing, supported by the theoretical clinical advantage of smoother dopamine receptor agon...
Two Parkinson's Disease Drugs May Cause Valvular Dysfunction CME
Medscape News
... were sharply and significantly increased compared with the remaining 19 cases who had not been receiving either drug or any other dopamine agonist — which in this analysis could have included bromocriptine, lisuride, pramipexole, or ro...
Google Co-founder and Parkinson's disease: What you need to know
Food Consumer
These drugs, which include bromocriptine, apomorphine, pramipexole, and ropinirole, mimic the role of dopamine in the brain. They can be given alone or in conjunction with levodopa. They may be used in the early stages of the disease, or la...
Parkinson's caused teacher's child porn habit, judge rules
Daily Telegraph
He said "hypersexuality", compulsive gambling and compulsive shopping had also been recognised as side-effects of the drugs Cabergoline and Ropinirole - which are both Dopamine Agonists. Carmichael took both. Cabergoline has since been with...
Paedophilia blamed on teacher's medication
The Independent
The defendant took both cabergoline and ropinirole, collectively known as dopamine agonists. Cabergoline has since been withdrawn from use. Judge Mary Jane Mowat described the case as "wholly exceptional", and said it was clear that Mr Carm...
Restless Legs Syndrome
KVBC
For daily symptoms, two medications, pramipexole (Mirapex) and ropinirole (Requip) that increase the amount of dopamine in the brain are used on a daily basis. Other medications such as benzodiazepines and opiates help induce sleep and ofte...
Fine-Tuning the Design of GPCR Therapeutics
Genetic Engineering News
Surprisingly, some are drugs prescribed today such as ropinirole for restless leg syndrome, guafacine for hypertension, oxymetazoline in over-the-counter decongestants, and quinidine for antirhythmia. None were previously known to act throu...
Forecast Insight - Parkinson's Disease - Market upgrade following ...
PR Inside
GlaxoSmithKline´s Requip XL (ropinirole extended-release) is set to become the market leading dopamine agonist in 2009. The convenience of once-daily dosing, supported by the theoretical clinical advantage of smoother dopamine receptor agon...